Výsledky vyhledávání - "KATRIN PEGELOW"

Akademický článek

Cyclospora cayetanensis Among Expatriate and Indigenous Populations of West Java, Indonesia

Autor: David J. Fryauff, Reinhard Krippner, Purnomo Prodjodipuro, Christa Ewald, Shirley Kawengian, Katrin Pegelow, Thomas Yun, Claudia von Heydwolff-Wehnert, Buhari Oyofo, Rainer Gross

Publikováno v: Emerging Infectious Diseases, Vol 5, Iss 4, Pp 585-588 (1999)

From January 1995 through July 1998, we investigated the occurrence of Cyclospora cayetanensis infection associated with gastrointestinal illness or diarrhea in foreign residents and natives of West Java, Indonesia. We found that C. cayetanensis was

Externí odkaz: https://doaj.org/article/21630a3ace74427c8ccd9cf7803ee32f

Zobrazit plný text záznamu

Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics

Autor: Philip D, Home, Rory J, McCrimmon, Julio, Rosenstock, Matthias, Blüher, Katrin, Pegelow, Lydie, Melas-Melt, Khier, Djaballah, Francesco, Giorgino

Publikováno v: Diabetes, Obesity and Metabolism. 25:656-663

To report prespecified and post hoc analyses of the SoliMix dataset exploring the impact of baseline participant characteristics on the original SoliMix study outcomes, to enable informed treatment choices for people with different biomedical charact

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8aec36c52f748b8fa67635199e1ab7
https://doi.org/10.1111/dom.14907

Zobrazit plný text záznamu

846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

Autor: PHILIP HOME, JULIO ROSENSTOCK, FRANCESCO GIORGINO, MATTHIAS BLÜHER, KHIER DJABALLAH, KATRIN PEGELOW, LYDIE MELAS-MELT, RORY J. MCCRIMMON

Publikováno v: Diabetes. 71

Introduction: SoliMix (EudraCT: 2017-003370-13) found better HbA1c, weight benefit, and lower hypoglycemia risk with iGlarLixi vs. premix BIAsp 30 in people with type 2 diabetes (T2D) advancing from basal insulin (BI) + oral antihyperglycemic drugs (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0fbd6bee110b7e242d9f5f73c283e7e4
https://doi.org/10.2337/db22-846-p

Zobrazit plný text záznamu

845-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI

Autor: PHILIP HOME, RORY J. MCCRIMMON, JULIO ROSENSTOCK, MATTHIAS BLÜHER, KATRIN PEGELOW, LYDIE MELAS-MELT, KHIER DJABALLAH, FRANCESCO GIORGINO

Publikováno v: Diabetes. 71

Introduction: SoliMix (EudraCT: 2017-003370-13) found better HbA1c, weight benefit, and lower hypoglycemia risk requiring less insulin with once-daily iGlarLixi vs. twice-daily premix BIAsp 30 in people with type 2 diabetes (T2D) advancing from basal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f7dde1ec478739d630ad113fbfceb70
https://doi.org/10.2337/db22-845-p

Zobrazit plný text záznamu

Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL: A sub‐analysis of the Titration and OPtimisation (TOP) registry

Autor: Jochen Seufert, Martin Pfohl, Katrin Pegelow, Peter Bramlage, Andreas Fritsche, Stefan Pscherer, Helmut Anderten, Anja Borck

Publikováno v: Diabetes, Obesity and Metabolism. 21:2169-2173

The aim of this study was to identify predictors of long-term response to the initiation of basal-supported oral therapy (BOT) with insulin glargine (IGlar-100). Patients from the observational TOP registry were grouped based on those who had achieve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6033a9d71ff49fa3e66759b5e943e820
https://doi.org/10.1111/dom.13768

Zobrazit plný text záznamu

Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety

Autor: Martin Pfohl, Katrin Pegelow, Helmut Anderten, Jochen Seufert, Andreas Fritsche, Peter Wiesli, Stefan Pscherer

Publikováno v: Diabetes Obes. Metab., DOI: 10.1111/dom.14549 (2021)

AIMS This study evaluated the effectiveness and safety of switching the basal insulin (BI) in a BI-supported oral therapy (BOT) to insulin glargine 300 U/ml (Gla-300) in adults with inadequately controlled type 2 diabetes (T2D). MATERIALS AND METHODS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ac952c0e48e3dacd2ee2d5f6478e657
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=63062

Zobrazit plný text záznamu

Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting

Autor: Martin Pfohl, Stefan Pscherer, Helmut Anderten, Jochen Seufert, Katrin Pegelow, Andreas Fritsche, François R Jornayvaz

Publikováno v: Diabetes, Obesity and Metabolism, Vol. 22, No 5 (2020) pp. 759-766
Diabetes, Obesity & Metabolism
Diabetes Obes. Metab. 22, 759-766 (2020)

Aim To evaluate the effectiveness and safety of initiating basal insulin-supported oral therapy (BOT) with insulin glargine 300 U/mL (Gla-300) in patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs (OADs). Materials and M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b8d571d919ae8f9f0554d4b6da151d
https://archive-ouverte.unige.ch/unige:138892

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání